Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5387 ARTÍCULOS , VIENDO DEL 1651 AL 1665

Rational Design of Novel Therapies for Pantothenate Kinase-Associated Neurodegeneration

Thakur N, Klopstock T, Jackowski S, Kuscer E, Tricta F, Videnovic A, Jinnah HA.

Mov Disord. 2021 Sep;36(9):2005-2016. doi: 10.1002/mds.28642. Epub 2021 May 18.

Neurodegeneration with Brain Iron Accumulation and a Brief Report of the Disease in Iran

Hajati R, Emamikhah M, Danaee Fard F, Rohani M, Alavi A.

Can J Neurol Sci. 2022 May;49(3):338-351. doi: 10.1017/cjn.2021.124. Epub 2021 Jun 4.

Review of Tone Management for the Primary Care Provider

McClugage SG 3rd, Bauer DF.

Pediatr Clin North Am. 2021 Aug;68(4):929-944. doi: 10.1016/j.pcl.2021.04.018.

Incidental Finding of MEGDEL Syndrome Based on Neuroimaging: Case Report

Alshammari SA, Alghamdi FA, Alhazmi R, Aldossary S.

Case Rep Neurol. 2021 Jun 28;13(2):429-433. doi: 10.1159/000516319. eCollection 2021 May-Aug.

A consensus statement on the use of botulinum toxin in pediatric patients

Vova JA, Green MM, Brandenburg JE, Davidson L, Paulson A, Deshpande S, Oleszek JL, Inanoglu D, McLaughlin MJ.

PM R. 2022 Sep;14(9):1116-1142. doi: 10.1002/pmrj.12713. Epub 2021 Nov 26.

Prepontine placement of an intrathecal baclofen pump catheter for treatment of dystonia

Gianaris T, Holland RM, Villelli NW, Lee AE.

Surg Neurol Int. 2021 Sep 30;12:477. doi: 10.25259/SNI_146_2019. eCollection 2021.

Botulinum Neurotoxins in Central Nervous System: An Overview from Animal Models to Human Therapy

Luvisetto S.

Toxins (Basel). 2021 Oct 22;13(11):751. doi: 10.3390/toxins13110751.

Possible EIF2AK2-Associated Stress-Related Neurological Decompensation with Combined Dystonia and Striatal Lesions

Waller SE, Morales-Briceño H, Williams L, Mohammad SS, Fellner A, Kumar KR, Tchan M, Fung VSC.

Mov Disord Clin Pract. 2021 Dec 16;9(2):240-244. doi: 10.1002/mdc3.13384. eCollection 2022 Feb.

Crystallographic modeling of the PNPT1:c.1453A>G variant as a cause of mitochondrial dysfunction and autosomal recessive deafness; expanding the neuroimaging and clinical features

Hosseini Bereshneh A, Rezaei Z, Jafarinia E, Rajabi F, Ashrafi MR, Tavasoli AR, Garshasbi M.

Mitochondrion. 2021 Jul;59:1-7. doi: 10.1016/j.mito.2021.03.012. Epub 2021 Apr 1.

Emerging Disease-Modifying Therapies in Neurodegeneration With Brain Iron Accumulation (NBIA) Disorders

Iankova V, Karin I, Klopstock T, Schneider SA.

Front Neurol. 2021 Apr 15;12:629414. doi: 10.3389/fneur.2021.629414. eCollection 2021.

A novel ARX loss of function variant in female monozygotic twins is associated with chorea

Rodgers J, Calvert S, Shoubridge C, McGaughran J.

Eur J Med Genet. 2021 Nov;64(11):104315. doi: 10.1016/j.ejmg.2021.104315. Epub 2021 Aug 19.

Hypomyelination and Congenital Cataract

Wolf NI, Biancheri R, Zara F, Bruno C, Gazzerro E, Rossi A, van der Knaap MS, Minetti C.

2008 Oct 14 [updated 2021 Jan 14]. In: Adam MP, Bick S, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews(®) [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2026.

Novel Compound Heterozygous SACS Mutations in a Case with a Spasticity-Lacking Phenotype of Sacsin-Related Ataxia

Chen Y, Cen Z, Zheng X, Chen S, Xie F, Luo W.

Neurol India. 2021 Jan-Feb;69(1):219-221. doi: 10.4103/0028-3886.310115.

Copper deficiency-associated myelopathy in cryptogenic hyperzincemia: a case report

Mutti C, Bazzurri V, Tsantes E, Curti E, Parrino L, Granella F.

Acta Biomed. 2021 Feb 5;92(1):e2021054. doi: 10.23750/abm.v92i1.9730.

Clinical and biochemical footprints of inherited metabolic disease. V. Cerebral palsy phenotypes

Horvath GA, Blau N, Ferreira CR.

Mol Genet Metab. 2022 Dec;137(4):445-448. doi: 10.1016/j.ymgme.2021.03.008. Epub 2021 Mar 13.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias